A new clinical practice guideline from the American Academy of Sleep Medicine indicates that cognitive behavioral therapy for insomnia (CBT-I) alone remains the most effective first-line treatment for chronic insomnia, while adding medication may offer modest benefits for select outcomes such as total sleep time. The guideline is supported by […]
Recent recommendations of US guidelines highlight the importance of treating dyslipidemia earlier in life, refining cardiovascular risk assessment, and adopting lower LDL cholesterol targets to reduce long-term exposure to atherogenic lipoproteins and prevent atherosclerotic cardiovascular disease (ASCVD). Lifestyle counseling should begin in youth, with early pharmacologic therapy considered for individuals […]
Released in early 2026, the latest U.S. Dietary Guidelines champion a “real food” approach, advising Americans to prioritize whole foods like vegetables, fruits, proteins, and healthy fats while sharply limiting ultra-processed items, added sugars, and artificial additives. This update introduces significant shifts, including a higher daily protein recommendation, a move […]
Recent recommendations of the American College of Cardiology/American Heart Association Joint Committee emphasize that adults with congenital heart disease achieve better outcomes when managed at specialized adult congenital heart disease (ACHD) centers with multidisciplinary teams and close involvement of ACHD cardiologists, particularly for patients with moderate or complex anatomy or […]
The British Dietetic Association has developed the first comprehensive evidence-based dietary guidelines for the management of chronic constipation in adults. Four systematic reviews and meta-analyses encompassing 75 randomized controlled trials informed 59 recommendation statements, developed through the GRADE framework and Delphi consensus among a multidisciplinary Guideline Steering Committee. The recommendations […]
The updated US guidelines for high blood pressure (HBP) emphasize that HBP is the most common and modifiable risk factor for cardiovascular diseases—including coronary artery disease, heart failure, atrial fibrillation, stroke, dementia, chronic kidney disease, and all-cause mortality—with a treatment goal of <130/80 mm Hg for most adults, while allowing […]
The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of BP control appears to be worsening in North America, some European countries, and elsewhere around the world. The risk for cardiovascular diseases (CVD) attributable to BP is on a continuous log-linear exposure variable scale, not […]
The US guideline for the management of hypertrophic cardiomyopathy (HCM) have been updated. The top 10 take-home messages are: Shared decision-making is essential to provide the best clinical care. Referral to multidisciplinary HCM centers with appropriate expertise can be important to optimizing care for patients with HCM. Careful ascertainment of […]
The US 2023 atrial fibrillation (AF) guideline emphasizes a rhythm control strategy and highlight the need for lifestyle and risk factor modification in addition to medical treatment. Key points including: The new proposed classification of AF by 4 stages, recognizes AF as a disease continuum that requires a variety of […]